{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:13:47Z","timestamp":1791357227726,"version":"4.3.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T00:00:00Z","timestamp":1402531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s11096-014-9967-0","type":"journal-article","created":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T05:08:54Z","timestamp":1402463334000},"page":"815-820","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Clozapine-induced blood dyscrasias in Saudi Arab patients"],"prefix":"10.1007","volume":"36","author":[{"given":"Norah O.","family":"Abanmy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afnan","family":"Al-Jaloud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Al-Jabr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Al-Ruwaisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa","family":"Al-Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solafa","family":"Fatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,12]]},"reference":[{"issue":"3","key":"9967_CR1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","volume":"329","author":"JM Alvir","year":"1993","unstructured":"Alvir JM, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. N Engl J Med. 1993;329(3):162\u20137.","journal-title":"N Engl J Med"},{"issue":"7","key":"9967_CR2","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1176\/ajp.156.7.990","volume":"156","author":"K Wahlbeck","year":"1999","unstructured":"Wahlbeck K, Cheine M, Essali A, Adams C. Evidence of clozapine\u2019s effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. Am J Psychiatry. 1999;156(7):990\u20139.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"9967_CR3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1176\/appi.ajp.159.2.255","volume":"159","author":"J Volavka","year":"2002","unstructured":"Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, et al. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Am J Psychiatry. 2002;159(2):255\u201362.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"9967_CR4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/14740338.2.4.395","volume":"2","author":"RL Hall","year":"2003","unstructured":"Hall RL, Smith AG, Edwards JG. Haematological safety of antipsychotic drugs. Expert Opin Drug Saf. 2003;2(4):395\u20139.","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"9967_CR5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0033-3182(99)71206-5","volume":"40","author":"O Oyesanmi","year":"1999","unstructured":"Oyesanmi O, Kunkel EJ, Monti DA, Field HL. Hematologic side effects of psychotropics. Psychosomatics. 1999;40(5):414\u201321.","journal-title":"Psychosomatics"},{"issue":"7","key":"9967_CR6","first-page":"271","volume":"49","author":"JA Lieberman","year":"1988","unstructured":"Lieberman JA, Johns CA, Kane JM, Rai K, Pisciotta AV, Saltz BL, et al. Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs. J Clin Psychiatry. 1988;49(7):271\u20137.","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"9967_CR7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.5694\/j.1326-5377.1998.tb141414.x","volume":"168","author":"DL Copolov","year":"1998","unstructured":"Copolov DL, Bell WR, Benson WJ, Keks NA, Strazzeri DC, Johnson GF. Clozapine treatment in Australia: a review of haematological monitoring. Med J Aust. 1998;168(10):495\u20137.","journal-title":"Med J Aust"},{"key":"9967_CR8","volume-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","author":"RJ Baldessarini","year":"2006","unstructured":"Baldessarini RJ, Tarazi FI. Pharmacotherapy of psychosis and mania. In: Brunton L, Lazo J, Parker K, editors. Goodman & Gilman\u2019s the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006.","edition":"11"},{"key":"9967_CR9","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1192\/bjp.175.6.576","volume":"175","author":"J Munroe","year":"1999","unstructured":"Munroe J, O\u2019Sullivan D, Andrews C, Arana A, Mortimer A, Kerwin R. Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. Br J Psychiatry. 1999;175:576\u201380.","journal-title":"Br J Psychiatry"},{"key":"9967_CR10","unstructured":"BNF 62. British National Formulary. London: BMJ publishing and RPS publishing; 2011."},{"issue":"10","key":"9967_CR11","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/archpsyc.1990.01810220061007","volume":"47","author":"JA Lieberman","year":"1990","unstructured":"Lieberman JA, Yunis J, Eqea E, Canoso RT, Kane JM, Yunis EJ. HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia. Arch Gen Psychiatry. 1990;47(10):945\u20138.","journal-title":"Arch Gen Psychiatry"},{"key":"9967_CR12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S1461145798001023","volume":"1","author":"A Amar","year":"1998","unstructured":"Amar A, Segman RH, Shtrussberg S, Sherman L, Safirman C, Lerer B, et al. An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201. Int J Neuropsychopharmacol. 1998;1:41\u20134.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"9967_CR13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2370.1998.00091.x","volume":"25","author":"A Valevski","year":"1998","unstructured":"Valevski A, Klein T, Gazit E, Meged S, Stein D, Elizur A, et al. HLA-B38 and clozapine-induced agranulocytosis in Israeli Jewish schizophrenic patients. Eur J Immunogenet. 1998;25(1):11\u20133.","journal-title":"Eur J Immunogenet"},{"key":"9967_CR14","doi-asserted-by":"crossref","unstructured":"Lahdelma L, Ahokas A, Andersson LC, Suvisaari J, Hovatta I, Huttunen MO, et al. Mitchell B. Balter Award. Human leukocyte antigen-A1 predicts a good therapeutic response to clozapine with a low risk of agranulocytosis in patients with schizophrenia. J Clin Psychopharmacol. 2001;21(1):4\u20137.","DOI":"10.1097\/00004714-200102000-00002"},{"issue":"5","key":"9967_CR15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.tpj.6500423","volume":"7","author":"M Dettling","year":"2007","unstructured":"Dettling M, Cascorbi I, Opgen-Rhein C, Schaub R. Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigens. Pharmacogenomics J. 2007;7(5):325\u201332.","journal-title":"Pharmacogenomics J"},{"key":"9967_CR16","unstructured":"Freudenreich O, McEvoy J. 2012. Guidelines for prescribing clozapine in schizophrenia. [ONLINE] http:\/\/www.uptodate.com\/contents\/guifelines-for-prescribing-clozapine-in-schizophrenia?detectedLanguage=en&source=search_result&search=guidelines+for+prescribing+clozapine&selectedTitle=1~150&provider=noProvider . Accessed 5 March 2014."},{"key":"9967_CR17","unstructured":"Landaw SA, George JN. 2013. Approach to the adult patient with thrombocytopenia. [ONLINE] http:\/\/www.uptodate.com\/contents\/approach-to-the-adult-patient-with-thrombocytopenia . Accessed 5 March 2014."},{"key":"9967_CR18","unstructured":"Coates T. 2013. Approach to the patient with lymphocytosis or lymphocytopenia. [ONLINE] http:\/\/www.uptodate.com\/contents\/approach-to-the-patient-with-lymphocytosis-or-lymphocytopenia . Accessed 5 March 2014."},{"key":"9967_CR19","unstructured":"Weller P. 2013. Approach to the patient with eosinophilia. [ONLINE] http:\/\/www.uptodate.com\/contents\/approach-to-the-patient-with-eosinophilia?detectedLanguage=en&source=search_result&search=approach+to+the+patients+with+eosinophilia&selectedTitle=1~150&provider=noProvider . Accessed 5 March 2014."},{"issue":"5","key":"9967_CR20","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/schbul\/sbl068","volume":"33","author":"DL Kelly","year":"2007","unstructured":"Kelly DL, Kreyenbuhl J, Dixon L, Love RC, Medoff D, Conley RR. Clozapine underutilization and discontinuation in African Americans due to leucopenia. Schizophr Bull. 2007;33(5):1221\u20134.","journal-title":"Schizophr Bull"},{"key":"9967_CR21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1192\/bjp.169.4.483","volume":"169","author":"K Atkin","year":"1996","unstructured":"Atkin K, Kendall F, Gould D, Freeman H, Liberman J, O\u2019Sullivan D. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. BJP. 1996;169:483\u20138.","journal-title":"BJP"},{"key":"9967_CR22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2165\/00023210-199707020-00005","volume":"7","author":"M Pirmohamed","year":"1997","unstructured":"Pirmohamed M, Park K. Mechanism of clozapine induced agranulocytosis: current status of research and implications for drug development. CNS Drugs. 1997;7:139\u201358.","journal-title":"CNS Drugs"},{"key":"9967_CR23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hup.917","volume":"23","author":"RJ Flanagan","year":"2008","unstructured":"Flanagan RJ, Dunk L. Haematological toxicity of drugs used in psychiatry. Hum Psychopharmacol Clin Exp. 2008;23:27\u201341.","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"9967_CR24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/13651501.2010.533181","volume":"15","author":"S Kadasah","year":"2011","unstructured":"Kadasah S, Arfin M, Tariq M. HAL-DRB1 association with schizophrenia in Saudi Arabian patients. Int J Psychiatry Clin Pract. 2011;15:112\u20137.","journal-title":"Int J Psychiatry Clin Pract"},{"key":"9967_CR25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2326-9-3","volume":"9","author":"S Denic","year":"2009","unstructured":"Denic S, Showqi S, Klein C, Takala M, Nagelkerke N, Agarwal MM. Prevalence, phenotype and inheritance of benign neutropenia in Arabs. BMC Blood Disord. 2009;9:3.","journal-title":"BMC Blood Disord"},{"key":"9967_CR26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000206841","volume":"69","author":"HG Jumean","year":"1983","unstructured":"Jumean HG, Sudah FI. Chronic benign idiopathic neutropenia in Jordanians. Acta Haematol. 1983;69:59\u201360.","journal-title":"Acta Haematol"},{"key":"9967_CR27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.imlet.2003.10.003","volume":"91","author":"SA Kaab","year":"2004","unstructured":"Kaab SA, Fadhli SA, Burhamah M, Aljafar H, Khamis A. Lymphocyte subsets in healthy adult Kuwaiti Arabs with relative benign ethnic neutropenia. Immunol Lett. 2004;91:49\u201353.","journal-title":"Immunol Lett"},{"key":"9967_CR28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.7326\/0003-4819-146-7-200704030-00004","volume":"146","author":"MM Hsieh","year":"2007","unstructured":"Hsieh MM, Everhart JE, Byrd-holt DD, Tisdale JF, Rodgers GP. Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med. 2007;146:486\u201392.","journal-title":"Ann Intern Med"},{"key":"9967_CR29","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/00007611-199310000-00021","volume":"86","author":"R Dust","year":"1993","unstructured":"Dust R, Dorevitch A, Franenkel Y. Platelet dysfunction associated with clozapine therapy. South Med J. 1993;86:1170\u20132.","journal-title":"South Med J"},{"issue":"6","key":"9967_CR30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2007-979577","volume":"29","author":"HJ Assion","year":"1996","unstructured":"Assion HJ, Kolbinger HM, Rao ML, Laux G. Lymphocytopenia and thrombocytopenia during treatment with risperidone or clozapine. Pharmacopsychiatry. 1996;29(6):227\u20138.","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"9967_CR31","first-page":"233","volume":"85","author":"GL Delilers","year":"2000","unstructured":"Delilers GL. Blood dyscrasias in clozapine-treated patients in Italy. Haematologica. 2000;85(3):233\u20137.","journal-title":"Haematologica"},{"issue":"12","key":"9967_CR32","first-page":"466","volume":"54","author":"MD Banov","year":"1993","unstructured":"Banov MD, Tohen M, Friedberg J. High risk of eosinophilia in women treated with clozapine. J Clin Psychiatry. 1993;54(12):466\u20139.","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"9967_CR33","first-page":"429","volume":"55","author":"M Hummer","year":"1994","unstructured":"Hummer M, Kurz M, Barnas C, Saria A, Fleischhacker WW. Clozapine-induced transient white blood count disorders. J Clin Psychiatry. 1994;55(10):429\u201332.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"9967_CR34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/JCP.0b013e31820e3d9d","volume":"31","author":"B Co\u015far","year":"2011","unstructured":"Co\u015far B, Taner ME, Eser HY, Alt\u0131n\u00f6z AE, Tarhan R. Does switching to another antipsychotic in patients with clozapine-associated granulocytopenia solve the problem? Case series of 18 patients. J Clin Psychopharmacol. 2011;31(2):169\u201373.","journal-title":"J Clin Psychopharmacol"},{"issue":"8","key":"9967_CR35","first-page":"449","volume":"26","author":"A Ben-Yehuda","year":"1990","unstructured":"Ben-Yehuda A, Bloom A, Lijovetzky G, Flusser D, Tur-Kaspa R. Chlorpromazine-induced liver and bone marrow granulomas associated with agranulocytosis. Isr J Med Sci. 1990;26(8):449\u201351.","journal-title":"Isr J Med Sci"},{"issue":"6","key":"9967_CR36","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1345\/aph.18468","volume":"34","author":"B Hirshberg","year":"2000","unstructured":"Hirshberg B, Gural A, Caraco Y. Zuclopenthixol-associated neutropenia and thrombocytopenia. Ann Pharmacother. 2000;34(6):740\u20132.","journal-title":"Ann Pharmacother"},{"key":"9967_CR37","unstructured":"Clozapine. In: DRUGDEX system [CD-ROM]. Volume 159. Truven Health Analytics; 2014 (expires March 2014)."},{"key":"9967_CR38","first-page":"254","volume":"119","author":"AV Pisciotta","year":"1992","unstructured":"Pisciotta AV, Konings SA, Ciesemier LL, Cronkite CE, Lieberman JA. Cytotoxic activity in serum of patients with clozapine-induced agranulocytosis. J Lab Clin Med. 1992;119:254\u20136.","journal-title":"J Lab Clin Med"},{"key":"9967_CR39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1176\/ps.47.1.52","volume":"47","author":"G Honigfeld","year":"1996","unstructured":"Honigfeld G. Effects of the clozapine national registry system on incidence of deaths related to agranulocytosis. Psychiatric Serv. 1996;47:52\u20136.","journal-title":"Psychiatric Serv"},{"issue":"Suppl 3","key":"9967_CR40","first-page":"3","volume":"59","author":"G Honigfeld","year":"1998","unstructured":"Honigfeld G, Arellano F, Sethi J, Bianchini A, Schein J. Reducing clozapine-related morbidity and mortality: 5\u00a0years of experience with the clozaril national registry. J Clin Psychiatry. 1998;59(Suppl 3):3\u20137.","journal-title":"J Clin Psychiatry"},{"key":"9967_CR41","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2165\/00023210-199504060-00004","volume":"4","author":"AJ Mendelowitz","year":"1995","unstructured":"Mendelowitz AJ, Gerson SL, Alvir JJ, Lieberman JA. Clozapine-induced agranulocytosis. Risk factors, monitoring and management. CNS Drugs. 1995;4:412\u201321.","journal-title":"CNS Drugs"},{"key":"9967_CR42","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1182\/blood.V86.3.1177.1177","volume":"86","author":"JJ Yunis","year":"1995","unstructured":"Yunis JJ, Corzo D, Salazar M, Lieberman JA, Howard A, Yunis EJ. HLA associations in clozapine-induced agranulocytosis. Blood. 1995;86:1177\u201383.","journal-title":"Blood"},{"key":"9967_CR43","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1182\/blood.V89.11.4167","volume":"89","author":"D Turbay","year":"1997","unstructured":"Turbay D, Lieberman J, Alper CA, Delgado JC, Corzo D, Yunis JJ, et al. Tumor necrosis factor constellation polymorphism and clozapine induced agranulocytosis in two different ethnic groups. Blood. 1997;89:4167\u201374.","journal-title":"Blood"},{"issue":"8","key":"9967_CR44","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2217\/14622416.9.8.1101","volume":"9","author":"C Opgen-Rhein","year":"2008","unstructured":"Opgen-Rhein C, Dettling M. Clozapine-induced agranulocytosis and its genetic determinants. Pharmacogenomics. 2008;9(8):1101\u201311.","journal-title":"Pharmacogenomics"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-014-9967-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-014-9967-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-014-9967-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T05:38:13Z","timestamp":1689313093000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-014-9967-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,12]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["9967"],"URL":"https:\/\/doi.org\/10.1007\/s11096-014-9967-0","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,12]]}}}